Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors

Transplantation

Volumn 75, Issue 8, 2003, Pages 1356-1360

  Fenjves, Elizabeth S ^a   Ochoa, M Sofia ^a   Cabrera, Over ^a   Mendez, Armando J ^a   Kenyon, Norma S ^a   Inverardi, Luca ^a   Ricordi, Camillo ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CELL FUNCTION; CELL SORTER; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; NICK END LABELING; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET CELL; PRIMATE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; ERYTHROPOIETIN; HUMANS; IMMUNOLOGIC TECHNIQUES; INSULIN; ISLETS OF LANGERHANS; PRIMATES; RATS; RATS, INBRED LEW; RECEPTORS, ERYTHROPOIETIN; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0037469029     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000062862.88375.BD     Document Type: Conference Paper

References (30)

1. Wu H, Klingmuller U, Acurio A, et al. Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. Proc Natl Acad Sci USA 1997; 94: 1806-1810.
2. Nijhof W, de Haan G, Pietens J, et al. Mechanistic options of erythropoietin-stimulated erythropoiesis. Exp Hematol 1995; 23: 369-375.
3. Sato T, Maekawa T, Watanabe S, et al. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin. J Clin Invest 2000; 106: 263-270.
4. Bittorf T, Seiler J, Ludtke B, et al. Activation of STAT5 during EPO-directed suppression of apoptosis. Cell Signal 2000; 12: 23-30.
5. Youssoufian H, Longmore G, Neumann D, et al. Structure, function, and activation of the erythropoietin receptor. Blood 1993; 81: 2223-2236.
6. Juul SE, Joyce AE, Zhao Y, et al. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res 1999; 46: 263-268.
7. Ogilvie M, Yu X, Nicolas-Metral V, et al. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J Biol Chem 2000; 275: 39754-39761.
8. Bernaudin M, Bellail A, Marti HH, et al. Neurons and astrocytes express EPO mRNA: Oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 2000; 30: 271-278.
9. Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 1999; 55: 808-820.
10. Celik M, Gokmen N, Erbayraktar S, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 2002; 99: 2258-2263.
11. Siren AL, Fratelli M, Brines M, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 2001; 98: 4044-4049.
12. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 2148-2157.
13. Cattan P, Berney T, Schena S, et al. Early assessment of apoptosis in isolated islets of Langerhans. Transplantation 2001; 71: 857-862.
14. Biarnes M, Montolio M, Nacher V, et al. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002; 51: 66-72.
15. Lehmann R, Fernandez LA, Bottino R, et al. Evaluation of islet isolation by a new automated method (Coulter Multisizer Ile) and manual counting. Transplant Proc 1998; 30: 373-374.
16. Masuda S, Nagao M, Takahata K, et al. Functional erythropoietin receptor of the cells with neural characteristics: Comparison with receptor properties of erythroid cells. J Biol Chem 1993; 268: 11208-11216.
17. Harr SD, Uint L, Hollister R, et al. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease. J Neurochem 1996; 66: 2429-2435.
18. Rathmell JC, Thompson CB. The central effectors of cell death in the immune system. Annu Rev Immunol 1999; 17: 781-828.
19. Sawyer ST, Hankins WD. The functional form of the erythropoietin receptor is a 78-kDa protein: Correlation with cell surface expression, endocytosis, and phosphorylation. Proc Natl Acad Sci USA 1993; 90: 6849-6853.
20. Kurrer MO, Pakala SV, Hanson HL, et al. Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci USA 1997; 94: 213-218.
21. Su X, Hu Q, Kristan JM, et al. Significant role for Fas in the pathogenesis of autoimmune diabetes. J Immunol 2000; 164: 2523-2532.
22. Suarez-Pinzon WL, Power RF, Rabinovitch A. Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice. Diabetologia 2000; 43: 1149-1156.
23. Zhou YP, Teng D, Dralyuk F, et al. Apoptosis in insulin-secreting cells: Evidence for the role of intracellular Ca2+ stores and arachidonic acid metabolism. J Clin Invest 1998; 101: 1623-1632.
24. Macdougall IC, Roberts DE, Coles GA, et al. Clinical pharmacokinetics of epoetin (recombinant human erythropoietin). Clin Pharmacokinet 1991; 20: 99-113.
25. Silva M, Grillot D, Benito A, et al. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 1996; 88: 1576-1582.
26. Mulcahy L. The erythropoietin receptor. Semin Oncol 2001; 28: 19-23.
27. Hamamori Y, Samal B, Tian J, et al. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J Clin Invest 1995; 95: 1808-1813.
28. Svensson EC, Black HB, Dugger DL, et al. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum Gene Ther 1997; 8: 1797-1806.
29. Bartholomew A, Patil S, Mackay A, et al. Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum Gene Ther 2001; 12: 1527-1541.
30. Paillard F. The first physiologically regulated transgene for gene therapy: Erythropoietin. Hum Gene Ther 1997; 8: 1840-1841.